Literature DB >> 9669159

The effect of drug sampling policies on residents' prescribing.

D Brewer1.   

Abstract

BACKGROUND AND OBJECTIVES: Many clinical educators feel that the availability of drug samples has an influence on the prescribing habits of residents. Therefore, many programs limit the availability of samples. This study compares the prescriptions written in three family practice residency programs with different policies on availability of drug samples.
METHODS: We used a prospective observational design to compare three programs of similar size and curriculum but which differed in sampling policies. One program had no limitation of samples, one program limited samples to specifically approved drugs, and one program did not permit drug samples in the clinic. Carbonless duplicate prescriptions were collected and collated over the first 5 months of 1996, and prescribing of nonsteroidal anti-inflammatory drugs (NSAIDs) was monitored.
RESULTS: There was a greater percentage of generic prescriptions and use of preferred NSAIDs but no decrease in the "cost per prescription" in the programs that limited or eliminated samples when compared to the program with an "open" sample policy. There was no statistically significant difference between the program with no samples and the program that permitted only approved drugs.
CONCLUSIONS: The elimination or control of available drug samples is associated with differences in the prescriptions written by family practice residents, but this effect is fairly small.

Mesh:

Substances:

Year:  1998        PMID: 9669159

Source DB:  PubMed          Journal:  Fam Med        ISSN: 0742-3225            Impact factor:   1.756


  8 in total

1.  Effect of drug sample removal on prescribing in a family practice clinic.

Authors:  Daniel M Hartung; David Evans; Dean G Haxby; Dale F Kraemer; Gabriel Andeen; Lyle J Fagnan
Journal:  Ann Fam Med       Date:  2010 Sep-Oct       Impact factor: 5.166

Review 2.  Interactions between pharmaceutical representatives and doctors in training. A thematic review.

Authors:  Daniella A Zipkin; Michael A Steinman
Journal:  J Gen Intern Med       Date:  2005-08       Impact factor: 5.128

3.  Drug samples in family medicine teaching units: a cross-sectional descriptive study: Part 2: portrait of drug sample management in Quebec.

Authors:  Andréa Lessard; Marie-Thérèse Lussier; Fatoumata Binta Diallo; Michel Labrecque; Caroline Rhéaume; Pierre Pluye; Roland Grad
Journal:  Can Fam Physician       Date:  2018-12       Impact factor: 3.275

4.  Inventory of drug samples in a health care institution.

Authors:  Geneviève Soucy; Jean-François Bussières; Lyne Tardif; Benoît Bailey
Journal:  Can J Hosp Pharm       Date:  2009-07

5.  The effect of medication samples on self-reported prescribing practices: a statewide, cross-sectional survey.

Authors:  Richard G Pinckney; A Shams Helminski; Amanda G Kennedy; Charles D Maclean; Laurie Hurowitz; Elizabeth Cote
Journal:  J Gen Intern Med       Date:  2010-08-31       Impact factor: 5.128

6.  Free drug samples in the United States: characteristics of pediatric recipients and safety concerns.

Authors:  Sarah L Cutrona; Steffie Woolhandler; Karen E Lasser; David H Bor; David U Himmelstein; William H Shrank; Neal S LeLeiko
Journal:  Pediatrics       Date:  2008-10       Impact factor: 7.124

7.  Characteristics of recipients of free prescription drug samples: a nationally representative analysis.

Authors:  Sarah L Cutrona; Steffie Woolhandler; Karen E Lasser; David H Bor; Danny McCormick; David U Himmelstein
Journal:  Am J Public Health       Date:  2008-01-02       Impact factor: 9.308

8.  Rationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trial.

Authors:  William H Shrank; Niteesh K Choudhry; Daniel H Solomon; Thomas M Snedden; Thomas H Lee; Robert J Glynn; Theresa V Brown; Caitlin Jolda; Michelle Spetman; Maurice Alan Brookhart; Sebastian Schneeweiss; Jerry Avorn
Journal:  Am Heart J       Date:  2009-02-11       Impact factor: 4.749

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.